Oxymetazoline as a predictor of turbinate reduction surgery outcomes: Objective support from a prospective, single-blinded, computational fluid dynamics study.

adrenoceptor agonist computational fluid dynamics modeling oxymetazoline turbinate hypertrophy turbinate reduction α1 and α2‐adrenogeneic

Journal

International forum of allergy & rhinology
ISSN: 2042-6984
Titre abrégé: Int Forum Allergy Rhinol
Pays: United States
ID NLM: 101550261

Informations de publication

Date de publication:
12 Aug 2024
Historique:
revised: 02 07 2024
received: 28 03 2024
accepted: 19 07 2024
medline: 12 8 2024
pubmed: 12 8 2024
entrez: 12 8 2024
Statut: aheadofprint

Résumé

A patient's subjective response to topical nasal decongestant is often used to screen for turbinate reduction surgery suitability. However, this anecdotal strategy has not been objectively and quantitatively evaluated. Prospective, longitudinal, and single-blinded cohort study employing computational fluid dynamic modeling based on computed tomography scans at baseline, 30 min postoxymetazoline, and 2 months postsurgery on 11 patients with chronic turbinate hypertrophy. Nasal obstruction symptom evaluation (NOSE) and visual analogue scale (VAS) obstruction scores significantly improved from baseline to postoxymetazoline and again to postsurgery (NOSE: 71.82 ± 14.19 to 42.27 ± 25.26 to 22.27 ± 21.04; VAS: 6.09 ± 2.41 to 4.14 ± 2.20 to 2.08 ± 1.56; each interaction p < 0.05), with significant correlation between the latter two states (r∼0.37-0.69, p < 0.05). Oxymetazoline had a broader anatomical impact throughout inferior and middle turbinates than surgery (many p < 0.05); however, the improvement in regional airflow is similar (most p > 0.05) and predominantly surrounding the inferior turbinate. Strong postoxymetazoline to postsurgery correlations were observed in decreased nasal resistance (r = 0.79, p < 0.05), increased regional airflow rates (r = -0.47 to -0.55, p < 0.05) and regional air/mucosa shear force and heat flux (r = 0.43 to 0.58, p < 0.05); however, only increasing peak heat flux significantly correlated to symptom score improvement (NOSE: r = 0.48, p < 0.05). We present the first objective evidence that the "topical decongestant test" can help predict turbinate reduction surgery outcomes. The predictive effect is driven by similar improvementin regional airflow that leading to improved air/mucosa stimulations (peak heat flux) rather than through reduced nasal resistance.

Sections du résumé

BACKGROUND BACKGROUND
A patient's subjective response to topical nasal decongestant is often used to screen for turbinate reduction surgery suitability. However, this anecdotal strategy has not been objectively and quantitatively evaluated.
METHODS METHODS
Prospective, longitudinal, and single-blinded cohort study employing computational fluid dynamic modeling based on computed tomography scans at baseline, 30 min postoxymetazoline, and 2 months postsurgery on 11 patients with chronic turbinate hypertrophy.
RESULTS RESULTS
Nasal obstruction symptom evaluation (NOSE) and visual analogue scale (VAS) obstruction scores significantly improved from baseline to postoxymetazoline and again to postsurgery (NOSE: 71.82 ± 14.19 to 42.27 ± 25.26 to 22.27 ± 21.04; VAS: 6.09 ± 2.41 to 4.14 ± 2.20 to 2.08 ± 1.56; each interaction p < 0.05), with significant correlation between the latter two states (r∼0.37-0.69, p < 0.05). Oxymetazoline had a broader anatomical impact throughout inferior and middle turbinates than surgery (many p < 0.05); however, the improvement in regional airflow is similar (most p > 0.05) and predominantly surrounding the inferior turbinate. Strong postoxymetazoline to postsurgery correlations were observed in decreased nasal resistance (r = 0.79, p < 0.05), increased regional airflow rates (r = -0.47 to -0.55, p < 0.05) and regional air/mucosa shear force and heat flux (r = 0.43 to 0.58, p < 0.05); however, only increasing peak heat flux significantly correlated to symptom score improvement (NOSE: r = 0.48, p < 0.05).
CONCLUSION CONCLUSIONS
We present the first objective evidence that the "topical decongestant test" can help predict turbinate reduction surgery outcomes. The predictive effect is driven by similar improvementin regional airflow that leading to improved air/mucosa stimulations (peak heat flux) rather than through reduced nasal resistance.

Identifiants

pubmed: 39132819
doi: 10.1002/alr.23422
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024 The Author(s). International Forum of Allergy & Rhinology published by Wiley Periodicals LLC on behalf of American Academy of Otolaryngic Allergy and American Rhinologic Society.

Références

Nunez DA, Bradley PJ. A randomised clinical trial of turbinectomy for compensatory turbinate hypertrophy in patients with anterior septal deviations. Clin Otolaryngol Allied Sci. 2000;25(6):495‐498. doi:10.1046/j.1365–2273.2000.00362.x
Grymer LF, Illum P, Hilberg O. Septoplasty and compensatory inferior turbinate hypertrophy: a randomized study evaluated by acoustic rhinometry. J Laryngol Otol. 1993;107(5):413‐417. doi:10.1017/S0022215100123308
Akhouri S, House SA. Allergic Rhinitis. StatPearls. StatPearls Publishing; 2023. Accessed. 2023. http://www.ncbi.nlm.nih.gov/books/NBK538186/
Arikan OK, Koc C, Kendi T, Muluk NB, Ekici A. CT assessment of the effect of fluticasone propionate aqueous nasal spray treatment on lower turbinate hypertrophy due to vasomotor rhinitis. Acta Otolaryngol (Stockh). 2006;126(1):37‐42. doi:10.1080/00016480510012219
Leader P, In GeigerZVasomotorRhinitis, : StatPearls. StatPearls Publishing; 2023. Accessed 2023. http://www.ncbi.nlm.nih.gov/books/NBK547704/
Bhattacharyya N, Ambulatory sinus and nasal surgery in the United States: demographics and perioperative outcomes. Laryngoscope. 2010;120(3):635‐638. doi:10.1002/lary.20777
Bende M, Löth S. Vascular effects of topical oxymetazoline on human nasal mucosa. J Layngology Otol. 1986;100(3):285‐288. doi:10.1017/S0022215100099151
Zhao K, Blacker K, Luo Y, Bryant B, Jiang J. Perceiving nasal patency through mucosal cooling rather than air temperature or nasal resistance. PLoS One. 2011;6(10):e24618. doi:10.1371/journal.pone.0024618
Zhao K, Jiang J, Blacker K, et al. Regional peak mucosal cooling predicts the perception of nasal patency. Laryngoscope. 2014;124(3):589‐595. doi:10.1002/lary.24265
Root ZT, Lepley TJ, Wu Z, et al. How does oxymetazoline change nasal aerodynamics and symptomatology in patients with turbinate hypertrophy?. Laryngoscope. 2023:lary30968. doi:10.1002/lary.30968. Published online August.
Stewart M, Witsell D, Smith T, Weaver E, Yueh B, Hannley M, Development and validation of the nasal obstruction symptom evaluation (NOSE) scale. Otolaryngol Neck Surg. 2004;130(2):157‐163. doi:10.1016/j.otohns.2003.09.016
Lepley T, Wu Z, Root ZT, et al. Can oxymetazoline simulate the outcomes of septoplasty and inferior turbinate reduction surgery? Infer Turbinate Reduct Surg. 2022;13(5):961‐963.
Zhao K, Scherer P, Hajiloo S, Dalton P. Effect of anatomy on human nasal air flow and odorant transport patterns: implications for olfaction. Chem Senses. 2004;29(5):365‐379. doi:10.1093/chemse/bjh033
Zhao K, Jiang J. What is normal nasal airflow? A computational study of 22 healthy adults. Int Forum Allergy Rhinol. 2014;4(6):435‐446. doi:10.1002/alr.21319
Li C, Jiang J, Dong H, Zhao K. Computational modeling and validation of human nasal airflow under various breathing conditions. J Biomech. 2017;64:59‐68. doi:10.1016/j.jbiomech.2017.08.031
Maza G, Li C, Krebs J, et al. Computational fluid dynamics after endoscopic endonasal skull base surgery‐possible empty nose syndrome in the context of middle turbinate resection. Int Forum Allergy Rhinol. 2019;9(2):204‐211. doi:10.1002/alr.22236
Root ZT, Schneller AR, Lepley TJ, Wu Z, Zhao K. Computational fluid dynamics and its potential applications for the ENT clinician. Facial Plast Surg. 2024;40(3):323‐330. doi:10.1055/s‐0043‐1778072. Published online.
Zhao K, Malhotra P, Rosen D, Dalton P, Pribitkin EA. Computational fluid dynamics as surgical planning tool: a pilot study on middle turbinate resection: CFD and nasal surgery. Anat Rec. 2014;297(11):2187‐2195. doi:10.1002/ar.23033
Li C, Jiang J, Kim K, et al. Nasal structural and aerodynamic features that may benefit normal olfactory sensitivity. Chem Senses. 2018;43(4):229‐237. doi:10.1093/chemse/bjy013
Li C, Farag AA, Maza G, et al. Investigation of the abnormal nasal aerodynamics and trigeminal functions among empty nose syndrome patients. Int Forum Allergy Rhinol. 2018;8(3):444‐452. doi:10.1002/alr.22045
Lindemann J, Leiacker R, Rettinger G, Keck T. Nasal mucosal temperature during respiration. Clin Otolaryngol Allied Sci. 2002;27(3):135‐139. doi:10.1046/j.1365–2273.2002.00544.x
Sullivan CD, Garcia GJM, Frank‐Ito DO, Kimbell JS, Rhee JS. Perception of better nasal patency correlates with increased mucosal cooling after surgery for nasal obstruction. Otolaryngol Neck Surg. 2014;150(1):139‐147. doi:10.1177/0194599813509776
Malik J, Spector BM, Wu Z, et al. Evidence of nasal cooling and sensory impairments driving patient symptoms with septal deviation. Laryngoscope. 2022;132(3):509‐517. doi:10.1002/lary.29673
Hsu HC, Tan CD, Chang CW, et al. Evaluation of nasal patency by visual analogue scale/nasal obstruction symptom evaluation questionnaires and anterior active rhinomanometry after septoplasty: a retrospective one‐year follow‐up cohort study. Clin Otolaryngol. 2017;42(1):53‐59. doi:10.1111/coa.12662
Sozansky J, Houser SM. The physiological mechanism for sensing nasal airflow: a literature review. Int Forum Allergy Rhinol. 2014;4(10):834‐838. doi:10.1002/alr.21368
Wu Z, Krebs JP, Spector BM, Otto BA, Zhao K, Farag AA, Regional peak mucosal cooling predicts radiofrequency treatment outcomes of nasal valve obstruction. Laryngoscope. 2021;131(6). doi:10.1002/lary.29223
Tu J, Yeoh GH, Liu C, Tao Y. Computational Fluid Dynamics: A Practical Approach. Butterworth‐Heinemann, an imprint of Elsevier; 2024. Fourth edition.
Kimbell JS, Frank DO, Laud P, Garcia GJM, Rhee JS. Changes in nasal airflow and heat transfer correlate with symptom improvement after surgery for nasal obstruction. J Biomech. 2013;46(15):2634‐2643. doi:10.1016/j.jbiomech.2013.08.007

Auteurs

Zachary T Root (ZT)

Department of Otolaryngology - Head & Neck Surgery, The Ohio State University, Columbus, Ohio, USA.

Zhenxing Wu (Z)

Department of Otolaryngology - Head & Neck Surgery, The Ohio State University, Columbus, Ohio, USA.

Thomas J Lepley (TJ)

Department of Otolaryngology - Head & Neck Surgery, The Ohio State University, Columbus, Ohio, USA.

Aspen R Schneller (AR)

Department of Otolaryngology - Head & Neck Surgery, The Ohio State University, Columbus, Ohio, USA.

Robbie J Chapman (RJ)

Department of Otolaryngology - Head & Neck Surgery, The Ohio State University, Columbus, Ohio, USA.

Veronica L Formanek (VL)

Department of Otolaryngology - Head & Neck Surgery, The Ohio State University, Columbus, Ohio, USA.

Kathleen M Kelly (KM)

Department of Otolaryngology - Head & Neck Surgery, The Ohio State University, Columbus, Ohio, USA.

Bradley A Otto (BA)

Department of Otolaryngology - Head & Neck Surgery, The Ohio State University, Columbus, Ohio, USA.

Kai Zhao (K)

Department of Otolaryngology - Head & Neck Surgery, The Ohio State University, Columbus, Ohio, USA.

Classifications MeSH